WILLIAM SHOUGH: Open Payments
NPI 1184060972 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,252 in 142 payments from 27 companies in 2025. Trend: 2023 $2,916 · 2024 $3,090 · 2025 $2,252
Food & beverage: $2,252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $360 |
| PFIZER INC. | 19 | $195 |
| Novo Nordisk Inc | 11 | $193 |
| Lilly USA, LLC | 12 | $170 |
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| Lundbeck LLC | 12 | $141 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $102 |
| Phathom Pharmaceuticals, Inc. | 5 | $90 |
| Abbott Laboratories | 5 | $90 |
Products named: REXULTI, NURTEC ODT, VRAYLAR, UBRELVY, MOUNJARO, CAPLYTA, JARDIANCE, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
